Swiss National Bank
KRTX

Swiss National Bank’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Swiss National Bank’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-63,100
Closed -$20M – 2544
2023
Q4 		$20M Sell
63,100
-6,900
-10% -$1.34M 0.01% 626
2023
Q3 		$11.8M Buy
70,000
+4,900
+8% +$921K 0.01% 803
2023
Q2 		$14.1M Buy
65,100
+5,700
+10% +$1.22M 0.01% 750
2023
Q1 		$10.8M Sell
59,400
-5,200
-8% -$995K 0.01% 837
2022
Q4 		$12.7M Buy
64,600
+1,300
+2% +$279K 0.01% 801
2022
Q3 		$14.2M Buy
63,300
+10,700
+20% +$2.17M 0.01% 721
2022
Q2 		$6.65M Buy
52,600
+3,500
+7% +$402K ﹤0.01% 1146
2022
Q1 		$6.22M Buy
49,100
+3,700
+8% +$417K ﹤0.01% 1311
2021
Q4 		$5.95M Sell
45,400
-100
-0.2% -$12.9K ﹤0.01% 1345
2021
Q3 		$5.57M Buy
45,500
+3,800
+9% +$439K ﹤0.01% 1382
2021
Q2 		$4.75M Buy
41,700
+14,100
+51% +$1.65M ﹤0.01% 1531
2021
Q1 		$3.32M Buy
27,600
+500
+2% +$56.6K ﹤0.01% 1699
2020
Q4 		$2.75M Buy
27,100
+400
+1% +$37.1K ﹤0.01% 1728
2020
Q3 		$2.06M Buy
26,700
+500
+2% +$42.6K ﹤0.01% 1704
2020
Q2 		$2.92M Buy
+26,200
New +$2.28M ﹤0.01% 1489

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Swiss National Bank's KRTX Position: Q1 2024 in Review

Swiss National Bank sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 63,100 shares — an estimated $20M sold.

Swiss National Bank first reported a position in KRTX in Q2 2020 and held it in 15 quarters. The position peaked at $20M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Swiss National Bank reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Swiss National Bank sold 63,100 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $20M.
  • Swiss National Bank first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2020 and held it in 15 quarters.
  • Swiss National Bank's Karuna Therapeutics, Inc. Common Stock position peaked at $20M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Swiss National Bank's 13F filing for Q1 2024, filed 7 May 2024.